Advertisement
Screener

EyePoint, Inc. (EYPT) Impairment of Intangible Assets, Finite-lived

2.5 / 5 stars · 47/94 Roast Me

EyePoint, Inc. Impairment of Intangible Assets, Finite-lived

EyePoint, Inc. (EYPT) reported Impairment of Intangible Assets, Finite-lived of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2024-03-08

  • EyePoint, Inc. impairment of intangible assets, finite-lived for the quarter ending 2012-06-30 was $0.00.
  • EyePoint, Inc. impairment of intangible assets, finite-lived for the quarter ending 2012-03-31 was $0.00.
  • EyePoint, Inc. impairment of intangible assets, finite-lived for the quarter ending 2011-12-31 was $14.80M.
  • EyePoint, Inc. impairment of intangible assets, finite-lived for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • EyePoint, Inc. impairment of intangible assets, finite-lived for fiscal 2022 was $20.70M.
  • EyePoint, Inc. impairment of intangible assets, finite-lived for fiscal 2021 was $0.00.
  • EyePoint, Inc. impairment of intangible assets, finite-lived for fiscal 2012 was $14.83M.
Period endImpairment of Intangible Assets, Finite-lived 3 monthImpairment of Intangible Assets, Finite-lived 3 month as first filedImpairment of Intangible Assets, Finite-lived 6 monthImpairment of Intangible Assets, Finite-lived 9 monthImpairment of Intangible Assets, Finite-lived 12 month
2023-12-31$0.00
10-K · filed 2024-03-08
2022-12-31$20.70M
10-K · filed 2024-03-08
2021-12-31$0.00
10-K · filed 2023-03-10
2012-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11
$0.00
derived: sum of 2 quarters · filed 2014-09-11
$14.80M
derived: sum of 3 quarters · filed 2014-09-11
$14.83M
10-K · filed 2014-09-11
2012-03-31$0.00
derived: 10-Q 9 month − 10-K 6 month · filed 2013-05-14
$14.80M
derived: sum of 2 quarters · filed 2014-09-11
$14.83M
10-Q · filed 2013-05-14
2011-12-31$14.80M
10-K · filed 2014-09-11
$14.83M
10-Q · filed 2012-02-09
$14.83M
10-K · filed 2014-09-11
$14.80M
10-K · filed 2012-09-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
908 Devices Inc. (MASS)United States$0.476B-9.53
Quanterix Corp (QTRX)United States$0.150B-1.65
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15